Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thibault Mesplede

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Molecular and Cellular Biology|September 21, 2002
Repression by homeoprotein pitx1 of virus-induced interferon a promoters is mediated by physical interaction and trans repression of IRF3 and IRF7Marie-Laure Island, Thibault Mesplede, Nicole Darracq, et al.
Journal of Global Antimicrobial Resistance|February 17, 2020
Lamivudine-resistant HIV<sub>M184V</sub> is durably suppressed with dolutegravir plus lamivudine dual therapy in humanised miceSandra Medina-Moreno, Juan C Zapata, Fatah Kashanchi, et al.
Plos Pathogens|November 7, 2009
The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradationPeyman Nakhaei, Thibault Mesplede, Mayra Solis, et al.
Virology Journal|February 10, 2026
HIV-1 and HIV-2 interaction results in reduced cell infectivity and viral replication in vitroEdwin Magomere, Mark Appeaning, Nana-Ama Amoako, et al.
The Journal of Antimicrobial Chemotherapy|December 16, 2017
Dolutegravir reshapes the genetic diversity of HIV-1 reservoirsPierre Gantner, Guinevere Q Lee, David Rey, et al.
The Journal of Infectious Diseases|August 8, 2018
Reply to Darcis and BerkhoutIngeborg E A Wijting, Cynthia Lungu, Bart J A Rijnders, et al.
The Journal of Infectious Diseases|April 5, 2018
HIV-1 Resistance Dynamics in Patients With Virologic Failure to Dolutegravir Maintenance MonotherapyIngeborg E A Wijting, Cynthia Lungu, Bart J A Rijnders, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Molecular and Cellular Biology|September 21, 2002
Repression by homeoprotein pitx1 of virus-induced interferon a promoters is mediated by physical interaction and trans repression of IRF3 and IRF7Marie-Laure Island, Thibault Mesplede, Nicole Darracq, et al.
Journal of Global Antimicrobial Resistance|February 17, 2020
Lamivudine-resistant HIV<sub>M184V</sub> is durably suppressed with dolutegravir plus lamivudine dual therapy in humanised miceSandra Medina-Moreno, Juan C Zapata, Fatah Kashanchi, et al.
Plos Pathogens|November 7, 2009
The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradationPeyman Nakhaei, Thibault Mesplede, Mayra Solis, et al.
Virology Journal|February 10, 2026
HIV-1 and HIV-2 interaction results in reduced cell infectivity and viral replication in vitroEdwin Magomere, Mark Appeaning, Nana-Ama Amoako, et al.
The Journal of Antimicrobial Chemotherapy|December 16, 2017
Dolutegravir reshapes the genetic diversity of HIV-1 reservoirsPierre Gantner, Guinevere Q Lee, David Rey, et al.
The Journal of Infectious Diseases|August 8, 2018
Reply to Darcis and BerkhoutIngeborg E A Wijting, Cynthia Lungu, Bart J A Rijnders, et al.
The Journal of Infectious Diseases|April 5, 2018
HIV-1 Resistance Dynamics in Patients With Virologic Failure to Dolutegravir Maintenance MonotherapyIngeborg E A Wijting, Cynthia Lungu, Bart J A Rijnders, et al.
Pageof 2